RecallRadar

FDA Drug recall D-1067-2019

Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by Pharmacia & Upjohn Co, Divisio…

On 2019-04-10 the FDA classified a Class III recall of Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by Pharmacia & Upjohn Co, Divisio… by Pfizer, citing failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1067-2019
ClassificationClass III
Statusterminated
Initiated2019-03-15
Published2019-04-10
Last updated2026-09-13 11:52 UTC
CompanyPfizer
DistributionUS

Product

Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017, NDC 0009-6582-02

Reason

Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point

Identifiers

ndc0009-0870-21
ndc0009-0870-26
ndc0009-0775-20
ndc0009-0775-26
ndc0009-0902-11
ndc0009-0902-18
ndc0009-0728-05
ndc0009-0728-09
ndc0009-3124-01
ndc0009-3124-03
ndc0009-3447-01
ndc0009-3447-03
ndc0009-3381-01
ndc0009-3381-02
ndc0009-3375-01
ndc0009-3375-02
ndc0009-3382-01
ndc0009-3382-02
ndc0009-6582-02
ndc0009-6582-01
code_infoLot #: T97469, Exp. 7/2019, W28574, Exp.09/2019

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1067-2019%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.